Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.1850
0.00 (0.00%)
Dec 5, 2025, 5:28 PM CET

Celyad Oncology Market Cap

Celyad Oncology has a market cap or net worth of €8.28 million as of December 5, 2025. Its market cap has decreased by -69.25% in one year.

Market Cap
8.28M
Enterprise Value
8.32M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.19

Market Cap Chart

Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 8.28M, a decrease of -91.88%. That is a compound annual growth rate of -18.29%.

History

DateMarket Cap% Change
Dec 4, 20258.28M-71.93%
Dec 31, 202429.50M82.56%
Dec 29, 202316.16M41.33%
Dec 30, 202211.43M-85.60%
Dec 31, 202179.42M-13.96%
Dec 31, 202092.30M-31.75%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
argenx SE 47.82B
UCB SA 46.17B
Financière de Tubize 9.39B
Fagron NV 1.53B
Ion Beam Applications 321.93M
Onward Medical 187.68M
Hyloris Pharmaceuticals 165.20M
Nyxoah 156.37M
Market Cap Rankings